Cognis

Cognis was a German specialty-chemicals company headquartered in Monheim am Rhein, North Rhine-Westphalia. It supplied specialty chemicals and nutritional ingredients to industrial and consumer-facing markets, with a portfolio centered on natural-based chemistry, oleochemical raw materials, surfactants, and ingredients used in personal care and related applications. Rather than operating primarily as a commodity chemical producer, Cognis positioned itself around formulated and functional ingredients whose value depended on performance, application expertise, and the use of renewable or naturally derived feedstocks. The business developed from operations that had been integrated into Henkel, the German consumer-products and chemicals group. In 2000, the Cognis business became an operationally independent unit, separating its management and commercial identity from Henkel while retaining a heritage in chemical ingredients and applications. This independence was followed by a change in ownership. In November 2001, Cognis was acquired by a group of private-equity investors comprising Permira, Goldman Sachs Alternatives, and SV Life Sciences. Under this ownership structure, Cognis operated as an independent specialty-chemicals company rather than as a division of a large consumer-goods group. Cognis served customers internationally. Reference material describes production or service centers in almost 30 countries and a workforce of approximately 5,600 people. Its activities therefore combined manufacturing, technical service, application development, and international sales. The company’s principal areas included surfactants, oleochemicals, personal-care ingredients, and nutritional ingredients. These activities connected Cognis to a broad range of end uses, including cosmetics and toiletries, detergents and cleaning products, food and nutrition, and other industrial formulations. The company’s natural-based positioning was particularly relevant in markets where customers sought renewable feedstocks, mildness, biodegradability, or a stronger sustainability profile. Cognis later became the subject of a major strategic transaction. BASF agreed to acquire Cognis from Cognis Holding Luxembourg S.à r.l., the holding company controlled by the private-equity owners. The announced equity purchase price was €700 million. When net financial debt and pension obligations were included, the transaction’s stated enterprise value was €3.1 billion. Completion depended on approval from the relevant merger-control authorities. The transaction closed in December 2010. Following the closing, Cognis ceased to operate as an independent company and its businesses were integrated into BASF. The acquisition gave BASF additional specialty-chemicals and nutritional-ingredients activities, particularly in areas linked to renewable raw materials, surfactants, personal care, and food-related ingredients. Cognis is therefore best understood historically as a former international specialty-chemicals company and as a predecessor business whose capabilities and product activities became part of BASF after 2010. No separate current Cognis operating website, public listing, or independent corporate status is established in the supplied reference material.

Cognis was a German specialty-chemicals and nutritional-ingredients business with headquarters in Monheim am Rhein, in North Rhine-Westphalia. Its historical identity was shaped by three ownership phases: integration within Henkel, operational separation from Henkel, and ownership by private-equity investors before its acquisition by BASF. Before becoming an independent company, the business was part of Henkel, a major German consumer-products and chemicals group. Its activities were associated with chemical ingredients and specialty formulations rather than with a single consumer brand. The business supplied materials used by downstream manufacturers in applications such as personal care, detergents, nutrition, and other industrial products. Its technical role was to provide functional ingredients, including surfactants, oleochemical materials, and other chemistry based on natural or renewable raw materials. In 2000, the Cognis business became an operationally independent unit of Henkel. This change gave it a separate operating identity and prepared the business for a different ownership structure. It did not represent the creation of a consumer-facing product brand; instead, it marked the transition of an industrial chemicals activity toward independent corporate operation. Cognis’s later positioning emphasized specialty chemicals and nutritional ingredients, with sustainability and natural-based chemistry forming important parts of its market proposition. In November 2001, Cognis was acquired by private-equity funds associated with Permira, Goldman Sachs Alternatives, and SV Life Sciences. The transaction moved the company outside Henkel’s corporate structure. Cognis then operated as a standalone international supplier, developing and selling ingredients and specialty chemicals across multiple regions. Reference material states that the company had production or service centers in almost 30 countries and employed about 5,600 people. This footprint supported both manufacturing and the technical and commercial services needed by customers who incorporated Cognis ingredients into finished formulations. The company’s portfolio covered several connected fields. Surfactants served as functional ingredients in cleaning, personal-care, and industrial formulations. Oleochemicals used fats and oils as feedstocks and supported Cognis’s natural-based identity. Personal-care chemicals supplied the cosmetics and toiletries sector, where properties such as mildness, sensory performance, emulsification, and compatibility with other ingredients are commercially important. Nutritional ingredients extended the company’s activities into food and nutrition-related markets. Taken together, these businesses made Cognis a diversified specialty-ingredients supplier rather than a narrow producer serving only one end market. BASF agreed to acquire Cognis from Cognis Holding Luxembourg S.à r.l., the holding company controlled by the private-equity owners. The announced equity purchase price was €700 million. Including net financial debt and pension obligations, the transaction was assigned an enterprise value of €3.1 billion. Because the transaction required clearance from the relevant merger-control authorities, completion followed the regulatory process rather than occurring immediately upon announcement. The acquisition closed in December 2010. Cognis consequently ceased to exist as an independent corporate operator, and its businesses became part of BASF. For BASF, the transaction expanded its specialty-chemicals and ingredients activities in areas including surfactants, personal care, nutrition, and chemistry based on renewable raw materials. For Cognis, the closing marked the end of its independent period, which had begun with its operational separation from Henkel and continued through private-equity ownership. Cognis is therefore now principally a historical corporate identity and predecessor business within BASF rather than an active standalone brand.

1. 2010BASF announces acquisition agreement

   BASF agreed to acquire Cognis from Cognis Holding Luxembourg for an equity purchase price of €700 million, with an enterprise value of €3.1 billion including debt and pension obligations.

   Source
2. 2010Acquisition completed

   The transaction closed in December after the required merger-control review process.

   Source
3. 2001Acquisition by private-equity investors

   In November, Cognis was acquired by private-equity funds associated with Permira, Goldman Sachs Alternatives, and SV Life Sciences.

   Source
4. 2000Operational separation from Henkel

   The Cognis business became an operationally independent unit after having been integrated into Henkel.

   Source

International specialty-chemicals supplier emphasizing natural-based, renewable-feedstock, and application-oriented ingredients for personal care, detergents, nutrition, and industrial formulations.

• SurfactantsSpecialty chemicals

  Cognis supplied surfactant ingredients used to modify surface tension, support cleaning, stabilize formulations, and enable emulsification or wetting. These materials connected the company to detergent, personal-care, and industrial formulation markets. Their commercial value lay not only in the base chemical itself but also in performance, formulation compatibility, and the technical support provided to downstream manufacturers.

• OleochemicalsNatural-based chemicals

  Oleochemicals formed a central part of Cognis’s natural-based specialty-chemicals identity. Derived from fats and oils, these materials could be used as feedstocks or functional ingredients in a range of downstream products. The business linked oleochemical expertise with customer requirements around renewable raw materials, formulation performance, and applications in personal care, cleaning, nutrition, and other industrial sectors.

• Personal-care chemicalsPersonal-care ingredients

  Cognis supplied ingredients for cosmetics, toiletries, and other personal-care formulations. The category included specialty materials used for functions such as cleansing, emulsification, skin and hair conditioning, texture control, and sensory improvement. Cognis’s natural-based positioning was relevant to personal-care customers seeking renewable feedstocks and ingredient profiles aligned with sustainability-oriented product development.

• Nutritional ingredientsNutrition ingredients

  Nutritional ingredients extended Cognis beyond industrial formulation chemistry into food and nutrition-related applications. The business supplied ingredient technologies and materials for customers developing nutritional products. The available reference material identifies this as a major business area, but does not provide a sufficiently detailed product list to identify individual branded ingredients or product generations.

• Natural-based chemical ingredientsSpecialty chemicals

  Natural-based chemical ingredients were an overarching portfolio and positioning theme rather than one single product. Cognis emphasized chemistry derived partly or substantially from renewable natural feedstocks, especially fats and oils. These ingredients were developed for customers seeking specialty performance together with sustainability-related attributes, although the supplied sources do not specify a complete list of individual formulations.

• 2010Acquire CognisM&A

  BASF sought to acquire Cognis, an international supplier of specialty chemicals and nutritional ingredients with activities in natural-based chemistry, surfactants, oleochemicals, personal care, and nutrition.

  What changed. BASF agreed to purchase Cognis from Cognis Holding Luxembourg. The announced equity purchase price was €700 million; including net financial debt and pension obligations, the enterprise value was €3.1 billion.

  Aftermath. After merger-control clearance, the transaction closed in December 2010. Cognis ceased to operate independently and its businesses were integrated into BASF.

  Equity purchase price. €700 million (2010 announced transaction)

  Source
• 2001Sell Cognis to private-equity investorsM&A

  After becoming operationally independent from Henkel, Cognis changed ownership in a transaction involving private-equity funds.

  What changed. Permira, Goldman Sachs Alternatives, and SV Life Sciences acquired Cognis in November 2001.

  Aftermath. Cognis operated as an independent international specialty-chemicals company under private-equity ownership until its later sale to BASF.

  Source
• 2000Separate Cognis operationally from HenkelStrategy

  The Cognis business had previously been integrated into Henkel’s consumer-products and chemicals structure.

  What changed. Henkel made Cognis an operationally independent business unit, establishing a separate operating identity.

  Aftermath. The separation preceded Cognis’s sale to private-equity investors and its subsequent operation as an independent specialty-chemicals company.

  Source

• 2010BASF agrees to acquire Cognis

  BASF announced an agreement to acquire Cognis from Cognis Holding Luxembourg, whose controlling investors included Permira, Goldman Sachs Alternatives, and SV Life Sciences. The announced equity purchase price was €700 million, while the stated enterprise value including net financial debt and pension obligations was €3.1 billion.

  M&A
  Source
• 2010Cognis acquisition by BASF closes

  The BASF acquisition of Cognis was completed in December 2010 after the transaction was subject to clearance by the competent merger-control authorities.

  M&AOther
  Source

1. Cognis